Mental Health & Neurology

Unlock the Sleep-Brain Connection for Better Patient Outcomes

Contact

Advanced sleep and brain activity monitoring for comprehensive neurological & psychiatric care

Gain enhanced insights into the relationship between sleep disorders and mental health conditions. DormoVision X™ provides the objective, laboratory-grade neuro-sleep biomarkers essential for precision psychiatry and neurology. By capturing 38 channels of high-fidelity data—including a 6-channel EEG suite—clinicians can accurately quantify sleep architecture to identify REM fragmentation and Slow Wave Sleep (SWS) deficits linked to depression and cognitive decline.

Key Benefits

High-Resolution Neuro-Sleep Architecture
DormoVision X™ utilizes a 6-channel EEG suite (alongside EOG and EMG) to provide laboratory-grade sleep staging.
Unlike actigraphy or standard home tests that “estimate” sleep, this provides the Total Sleep Time (TST) and stage-specific data required to identify REM fragmentation or Slow Wave Sleep (SWS) deficits—key indicators in Depression and Early-Onset Dementia.

 

Clinically Validated Diagnostic Precision
The system demonstrated 96.6% severity classification agreement and a 0.97 Cohen’s Kappa compared to gold-standard in-lab PSG.
Clinicians can rely on longitudinal, objective data to track how psychiatric interventions (such as SSRIs or CBT-I) are physically altering the patient’s brain activity during sleep.

 

Longitudinal Monitoring in the Home Environment
A wireless, patient-friendly design allows for multi-night longitudinal analysis without the “first-night effect” of a lab.
Neurological and psychiatric conditions are often variable; capturing multiple nights of data in a natural environment provides a more accurate “baseline” for a patient’s neurobiological health than a single, stressful night in a clinic.

Features

  • One Platform, Full PSG Capability At Home or In-Lab.
  • Wireless, Remote, And FDA-Cleared.
  • 38 Total Channels For Comprehensive Sleep Data.
  • Faster Diagnoses with Greater Clinical Confidence.
  • Expand Capacity, Reduce Costs, No Added Overhead.

 

Validated via NCT06224972 (N=47)

  • Nox A1 Comparison: Virtually identical mean AHI values recorded head-to-head.

  • Severity Match: Near-perfect alignment in distinguishing mild, moderate, and severe OSA cases.

  • Signal Reliability: Strong correlations across all secondary sleep parameters with minimal variance.

Keep up to date with our latest news and announcements!

Sign up with Dormotech to stay up to date on upcoming events, releases, and new research.